Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Project description

New software to design patient-specific cancer vaccines

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines
• medical and health sciences › clinical medicine › oncology
• natural sciences › biological sciences › genetics › RNA
• medical and health sciences › basic medicine › immunology › immunotherapy
• natural sciences › computer and information sciences › artificial intelligence › machine learning

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

ONCOIMMUNITY AS

Net EU contribution

€ 2 200 406,25

Address

Ullernchausseen 64
0379 Oslo
Norway

Region

Norge › Oslo og Viken › Oslo

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 943 031,25